NBIX Market Cap & Key Metrics
Neurocrine Biosciences, Inc.
$135.91
+$0.78(+0.58%)
53
Overall
70
Value
18
Tech
71
Quality
Market Cap
$13.82B
Volume
1.50M
52W Range
$122.14 - $186.12
Target Price
$206.03
NBIX market cap is $13.82B. This page lists Neurocrine Biosciences, Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
NBIX Key Metrics
- Market cap
- $13.82B
- P/E ratio (current-year EPS estimate)
- 18.72
- EPS estimate, current year
- $7.26
- EPS growth, 3-year
- +44.03%
- Value score
- 70
- Quality score
- 71
- Technical score
- 18
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $2.86B | $2.36B | $1.89B | $1.49B | $1.13B |
| EBITDA | $735.50M | $513.10M | $353.40M | $237.80M | $138.10M |
| EPS | $4.81 | $3.40 | $2.56 | $1.61 | $0.95 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NBIX | $135.91 | +0.6% | 1.50M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Neurocrine Biosciences, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW